UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 29, 2026 4:15 P.M.
Form:
S-1
CIK:
0001541157
Company Name:
Akari Therapeutics Plc
File Number:
333-292930